Morgan Stanley’s Chris Nicol on equity strategy, rates, the Aussie dollar, and capital management

In this wide-ranging interview, Nicol unpacks the key factors impacting markets right now and what they could mean for your portfolio.
Chris Conway

Livewire Markets

Note: This interview was taped on Monday 14 October 2024.

At any given time, there are a handful of dominant factors that could have an outsized impact on the future direction of markets.

And while investors might be aware of these factors and their ability to impact markets, formulating a view on them can be a challenge.

Fortunately for Livewire readers, I recently sat down with Chris Nicol, who is the Head of Australian Strategy and Macro at Morgan Stanley.

Given the wide-ranging nature of the conversation, the topics covered have been broken down into manageable sections below, focusing on the highlights from each. Alternatively, you can watch the full interview above.

Time Codes

0:00 - Intro
0:24 - Chris' background
1:33 - Views on the RBA and interest rates
3:50 - The Aussie dollar
5:13 - Australian equity strategy
6:58 - The Great Rotation
7: 39 - The state of the consumer
9:01 - The model portfolio: banks and miners
10:57 - China stimulus
12:38 - Overweight defensive industrials
13:54 - The model portfolio: tech and healthcare
16:14 - Franking credit war chests
19:17 - Yield, yield where are you?
20:38 - Chris' View from the Top

Chris Nicol, Head of Australian Strategy and Macro at Morgan Stanley.
Chris Nicol, Head of Australian Strategy and Macro at Morgan Stanley.

The RBA and the path for rates

To the dismay of those hoping for interest rate cuts, Nicol believes the RBA is not in a position to ease policy soon, noting that the central bank lagged behind other central banks in raising rates and will likely do the same on the way down.

When cuts eventually come, Nicol expects a shallow to normal cutting cycle. He cites Australia’s persistent inflation, particularly in rents and wages, as a factor that will challenge any aggressive easing moves by the RBA.

Nicol also expresses caution around the risk of global re-acceleration and the desire to avoid repeating historical cycles of excessive inflation and easing.

"They [central banks] don't want to repeat of the Volcker years. So I think every central bank is on notice for that. Our RBA wouldn't be on its own in that view", says Nicol. 

Aussie dollar outlook

Nicol is on record as predicting that the Australian dollar could strengthen to around 70 cents against the US dollar by the end of the year.

This projection is based on two factors: one is the RBA’s lag in easing monetary policy, which would typically put upward pressure on the currency, and the other is the global economic outlook. Potential soft landings and Chinese stimulus could boost Australian growth expectations together.

As for the potential impacts, Nicol believes a stronger Australian dollar could help mitigate inflation by reducing the risk of imported inflation. He suggests this may align with the RBA’s goals, as a higher currency would naturally contribute to price stability and take away any risk of inflation stalling.

Australian equity market and strategic positioning

Discussing the Australian equity market, Nicol notes the concentration and bifurcation within the market, particularly between large-cap stocks and other sectors. He explains that risk aversion and the need for liquidity have driven investors toward large-cap stocks, particularly banks, which have offered a compressed yield and a sense of safety.

Highlighting the concentration at the top end of the market, Nicol recounts the following observation:

“Over a period of time, if you'd just bought the best-performing, most-expensive stock in every sector over a 12-month view, you would've done okay, and that explains some of the narrative”.

However, Nicol also sees potential for a broader rotation into resources, contingent on factors like improved commodity prices and further Chinese stimulus. He notes that a recent period of underperformance in the resources sector relative to banks might signal opportunities for strategic rotation as global conditions improve.

What about the consumer?

Nicol hasn’t called this one perfectly over the journey and is self-aware when looking back.

“People that follow our work will say that I've probably been called the ‘boy who cried consumer’, just seeing interest rate rises, expecting that to bite into the economy.
When I try to back solve that over-caution that we had in terms of actual delivery of earnings for those sectors, it really came down to [the fact] that people kept their jobs and we saw a very strong jobs market", says Nicol. 

As for the current consumer environment, Nicol characterises it as one of “thrifting”, with consumers increasingly choosing cheaper options and reducing discretionary spending due to interest rate pressures.

He is cautious about expecting a cyclical recovery in consumer-driven sectors, as he anticipates this thrifting behaviour will persist and potentially dampen retail sales during the upcoming holiday season.

Strategies in mining and defensive industrials

Morgan Stanley’s model portfolio maintains an overweight position in mining stocks, despite a challenging year for this trade.

Nicol argues that the lack of investment in new resource supply has created favourable conditions for resource stocks, provided demand holds steady. As China eases monetary and fiscal policy, he sees potential for recovery in commodity prices, which would benefit mining stocks.

“You start to bring softer landing scenarios back into the equation, that's important because that allows the commodity signal to start to bounce and we've definitely seen that in iron ore”, says Nicol.

In addition, Morgan Stanley is overweight defensive industrial stocks, like telecommunications, infrastructure, and utilities names. Nicol believes these sectors offer some protection against volatility and benefit from lower long-term interest rates. He underscores the importance of having a defensive overlay to navigate the potentially choppy market outlook.

Quality growth: tech and healthcare

Tech has outperformed in recent months, while healthcare has lagged. Nicol attributes the relative underperformance of healthcare to earnings disruptions and sector-specific challenges.

Meanwhile, the Australian tech sector, though smaller than its US counterpart, has attracted institutional attention due to liquidity and structural tailwinds. Nicol believes investors looking for quality growth should consider blending healthcare and tech stocks, along with global growth-oriented companies, rather than seeing these sectors as exclusive options.

“When a broker comes to you and says you need more quality in your portfolio, you're probably needing to add healthcare and tech together," says Nicol.

Franking credit war chests

Many Australian companies have large reserves of franking credits, which have traditionally been distributed through buybacks. With recent regulatory changes limiting off-market buybacks, Nicol expects companies to explore alternative ways to return cash to shareholders, such as through special dividends.

He notes that repeated special dividend payments could signal to the market a company’s strong cash position, potentially leading to a re-rating of its stock.

“The expectation is starting to build that [consecutive special dividend payments] could feature, because if you just pay them once it's a sugar hit, it doesn't get reflected in long-term rerating.

“But if the market starts to think that a company has multiple periods of optionality to pay over and above your ordinary distribution schedule, that could actually be a rerating event for certain stocks”.

The hunt for yield

With the ASX 200’s forward yield of 3.6% at its lowest in years, Nicol acknowledges that yield compression is a challenge for yield-focused investors.

While current payout ratios remain aligned with historical averages, he suggests that a recovery in earnings coupled with potential increases in payout ratios could enhance yield. However, he emphasises that earnings growth is essential for a meaningful recovery in yield.

“The reality is an earnings recovery is going to be critical, with the payout ratio being maintained, with a little bit of flex in payout ratios should conditions really start to improve on an easing cycle basis”, says Nicol

View From the Top

As noted at the start of this wire, there is always plenty going on in markets and it’s not always easy to figure out what matters and what doesn’t.

In closing, Nicol shares the character traits he believes are required to stay ahead. 

Learn more about Morgan Stanley Wealth Management

Morgan Stanley's fundamental objective is to provide first-class service while helping their clients achieve their financial goals. Their Financial Advisers harness the firm’s global resources and intellectual capital to help create a financial plan tailored to you and your goals. Learn more here

........
Livewire gives readers access to information and educational content provided by financial services professionals and companies ("Livewire Contributors"). Livewire does not operate under an Australian financial services licence and relies on the exemption available under section 911A(2)(eb) of the Corporations Act 2001 (Cth) in respect of any advice given. Any advice on this site is general in nature and does not take into consideration your objectives, financial situation or needs. Before making a decision, please consider these and any relevant Product Disclosure Statement. Livewire has commercial relationships with some Livewire Contributors. The information and opinions in Morgan Stanley Research were prepared or are disseminated by Morgan Stanley & Co. LLC and/or Morgan Stanley C.T.V.M. S.A. and/or Morgan Stanley México, Casa de Bolsa, S.A. de C.V. and/or Morgan Stanley Canada Limited and/or Morgan Stanley & Co. International plc and/or Morgan Stanley Europe S.E. and/or RMB Morgan Stanley Proprietary Limited and/or Morgan Stanley MUFG Securities Co., Ltd. and/or Morgan Stanley Capital Group Japan Co., Ltd. and/or Morgan Stanley Asia Limited and/or Morgan Stanley Asia (Singapore) Pte. (Registration number 199206298Z) and/or Morgan Stanley Asia (Singapore) Securities Pte Ltd (Registration number 200008434H), regulated by the Monetary Authority of Singapore (which accepts legal responsibility for its contents and should be contacted with respect to any matters arising from, or in connection with, Morgan Stanley Research) and/or Morgan Stanley Taiwan Limited and/or Morgan Stanley & Co International plc, Seoul Branch, and/or Morgan Stanley Australia Limited (A.B.N. 67 003 734 576, holder of Australian financial services license No. 233742, which accepts responsibility for its contents), and/or Morgan Stanley Wealth Management Australia Pty Ltd (A.B.N. 19 009 145 555, holder of Australian financial services license No. 240813, which accepts responsibility for its contents), and/or Morgan Stanley India Company Private Limited having Corporate Identification No (CIN) U22990MH1998PTC115305, regulated by the Securities and Exchange Board of India (“SEBI”) and holder of licenses as a Research Analyst (SEBI Registration No. INH000001105), Stock Broker (SEBI Stock Broker Registration No. INZ000244438), Merchant Banker (SEBI Registration No. INM000011203), and depository participant with National Securities Depository Limited (SEBI Registration No. IN-DP-NSDL-567-2021) having registered office at 18th Floor, Tower 2, One World Center, Plot- 841, Jupiter Textile Mill Compound, Senapati Bapat Marg, Lower Parel, Mumbai 400013, India Telephone no. +91-22-61181000; Compliance Officer Details: Mr. Tejarshi Hardas, Tel. No.: +91-22-61181000 or Email: tejarshi.hardas@morganstanley.com; Grievance officer details: Mr. Tejarshi Hardas, Tel. No.: +91-22-61181000 or Email: msic-compliance@morganstanley.com which accepts the responsibility for its contents and should be contacted with respect to any matters arising from, or in connection with, Morgan Stanley Research, and their affiliates (collectively, "Morgan Stanley"). For important disclosures, stock price charts and equity rating histories regarding companies that are the subject of this report, please see the Morgan Stanley Research Disclosure Website at www.morganstanley.com/researchdisclosures, or contact your investment representative or Morgan Stanley Research at 1585 Broadway, (Attention: Research Management), New York, NY, 10036 USA. For valuation methodology and risks associated with any recommendation, rating or price target referenced in this research report, please contact the Client Support Team as follows: US/Canada +1 800 303-2495; Hong Kong +852 2848-5999; Latin America +1 718 754-5444 (U.S.); London +44 (0)20-7425-8169; Singapore +65 6834-6860; Sydney +61 (0)2-9770-1505; Tokyo +81 (0)3-6836-9000. Alternatively you may contact your investment representative or Morgan Stanley Research at 1585 Broadway, (Attention: Research Management), New York, NY 10036 USA. Analyst Certification The following analysts hereby certify that their views about the companies and their securities discussed in this report are accurately expressed and that they have not received and will not receive direct or indirect compensation in exchange for expressing specific recommendations or views in this report: Chris Nicol. Important Regulatory Disclosures on Subject Companies The equity research analysts or strategists principally responsible for the preparation of Morgan Stanley Research have received compensation based upon various factors, including quality of research, investor client feedback, stock picking, competitive factors, firm revenues and overall investment banking revenues. Equity Research analysts' or strategists' compensation is not linked to investment banking or capital markets transactions performed by Morgan Stanley or the profitability or revenues of particular trading desks. Morgan Stanley and its affiliates do business that relates to companies/instruments covered in Morgan Stanley Research, including market making, providing liquidity, fund management, commercial banking, extension of credit, investment services and investment banking. Morgan Stanley sells to and buys from customers the securities/instruments of companies covered in Morgan Stanley Research on a principal basis. Morgan Stanley may have a position in the debt of the Company or instruments discussed in this report. Morgan Stanley trades or may trade as principal in the debt securities (or in related derivatives) that are the subject of the debt research report. Certain disclosures listed above are also for compliance with applicable regulations in non-US jurisdictions.

Chris Conway
Managing Editor
Livewire Markets

My passion is equity research, portfolio construction, and investment education. There are some powerful processes that can help all investors identify great opportunities and outperform the market, and I want to bring them to life and share them...

I would like to

Only to be used for sending genuine email enquiries to the Contributor. Livewire Markets Pty Ltd reserves its right to take any legal or other appropriate action in relation to misuse of this service.

Personal Information Collection Statement
Your personal information will be passed to the Contributor and/or its authorised service provider to assist the Contributor to contact you about your investment enquiry. They are required not to use your information for any other purpose. Our privacy policy explains how we store personal information and how you may access, correct or complain about the handling of personal information.

Comments

Sign In or Join Free to comment